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ABSTRACT
Objective: There is an increased risk of coronary artery disease (CAD) in both diabetes and non-diabetes. Insulin resistance (IR) has been associated 
with the development of CAD in this both populations. However, there are not many studies on correlation between IR and severity of CAD in non-
diabetes. This study aimed to establish a correlation between IR and severity of CAD in non-diabetic individuals.
Methods: A cross-sectional study of 79 consecutive non-diabetic patients undergoing coronary angiogram for evaluation of clinically suspected CAD 
at a tertiary care hospital in Mangalore, Karnataka, were recruited. Clinical history, anthropometric, and biochemical parameters were analyzed. IR 
was determined by homeostasis model assessment-IR (HOMA-IR). The severity of CAD was assessed by Modified Gensini score. A Pearson correlation 
was done to find out the relation between HOMA-IR and Gensini core.
Results: The correlation between log of HOMA-IR and severity of CAD as assessed by Gensini score (r=−0.053 and p=0.64) was not significant in non-
diabetic patients. The correlations between severity of CAD and other known risk factors of CAD were also was not significant.
Conclusions: HOMA-IR is negatively associated with severity of CAD in non-diabetes.
Keywords: Insulin resistance, Coronary artery disease, Gensini score.
INTRODUCTION
The major cause of death worldwide is coronary artery disease (CAD), 
and more than 60% of the global burden of disease (GBD) occurs in 
developing countries [1,2]. GBD 2010 study showed that death from 
CAD increased by 87.8% between 1990 and 2010 in South Asia, and a 
further rise by 50% is expected by 2030 [3,4].
The Chennai Urban Population Study showed that the total prevalence 
of CAD was 9.1% among South Indian subjects with normal glucose 
tolerance [5]. Cardiovascular diseases have a multi-factorial 
causation, [6] and insulin resistance (IR) is one such non-conventional 
risk factor that can explain a major part of the pathogenesis of CAD [7].
IR increases the risk of CAD in both diabetics as well as non-
diabetics [8]. IR has also been identified as a factor in the development 
of atherosclerosis [9], and hyperinsulinemia has been associated with 
an increased death in CAD [10]. A significant positive linear correlation 
between IR and severity of coronary atherosclerosis has been shown 
in diabetics between the Indian populations [11]. However, there are 
not many studies in the same population that correlates the IR with the 
severity of coronary atherosclerosis quantitatively in non-diabetics. 
If we are able to establish a significant association between IR and 
severity of CAD, it would help us to identify the individuals who are 
likely to develop severe disease from the beginning itself.
In this study, IR is calculated by homeostasis model assessment-
IR (HOMA-IR) [12] and is correlated with the severity of coronary 
atherosclerosis as assessed by Modified Gensini score following a 
coronary angiogram [13] in non-diabetic individuals.
METHODS
In this cross-sectional study, 79 consecutive non-diabetic patients 
who satisfied the diagnostic criteria as recommended by the American 
Diabetes Association [14] and undergoing coronary angiogram for 
evaluation of clinically suspected CAD at a tertiary care hospital were 
recruited. The patients aged between 45 and 65 years were recruited, 
as studies show that beyond 65 years of age, the extent and degree 
of CAD remain same in all the population [15]. Patients with Type 2 
diabetes mellitus, on steroids, chronic kidney disease, and valvular 
heart diseases were excluded from the study. The study protocol was 
approved by the Institutional Ethics Committee. An informed consent 
was obtained from the study participants.
All the clinical findings were noted. Anthropometric measurements 
such as height, weight, waist, and hip circumference were noted as 
per standard norms [16]. Body mass index and waist-hip ratio were 
calculated. Biochemical parameters such as fasting blood sugar, 
fasting insulin, fasting lipid profile, glycated hemoglobin, and urine 
microalbumin were analyzed as previously described by Srinivasan 
et al. [11]. The degree of IR was measured by HOMA 2 computerized 
method [12]. In large epidemiological studies, the use of HOMA-IR has 
been shown to correlate well with the gold standard hyper-insulinemia 
euglycemic glucose clamp technique for the measurement of IR [17]. To 
achieve constant phase and to avoid changes in IR that may occur due 
to the burden of the disease and angiographic procedure, the blood 
test was done 2 weeks after coronary angiogram [18]. The Modified 
Gensini scoring method was used to assess the severity of CAD [13]. 
Gensini scoring was done by a cardiologist, who was blind to other 
parameters.
Statistical analysis
Data were expressed as mean±standard deviation. The correlation 
between these parameters was assessed by calculating Pearson’s 
correlation coefficient. p<0.05 was considered statistically significant. 
HOMA-IR values were logarithmically transformed for analysis [12]. 
Data were analyzed using statistical software for the social sciences 
(SPSS version 15, Chicago, IL, USA).
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RESULTS
The characteristics of the study population are shown in Table 1.
The mean age of the subjects was 57.36±8.08. The majority of the 
study population was males 64 (81%) and females 15 (19%). At the 
time of the study, 29 (37%) of the patients had been diagnosed with 
hypertension and were on antihypertensive treatment. The overall 
Gensini score ranged from 3 to 144 among non-diabetics.
The scatterplot representing the relation between Gensini score and IR 
in non-diabetic patients is shown in Fig. 1.
The correlation between log of HOMA-IR and severity of CAD as 
assessed by Gensini score (r=−0.053 and p=0.64) was not significant in 
non-diabetic patients.
The correlations between severity of CAD and other known risk factors 
of CAD were also not significant in non-diabetic patients (Table 2).
DISCUSSION
We have demonstrated the correlation between IR (HOMA-IR) and 
angiographic severity of CAD in 79 consecutive non-diabetic patients 
who underwent angiogram for the screening of clinically suspected 
CAD.
Our study showed that the severity of CAD is not associated with IR in 
the non-diabetic population, which is similar to a study by Kruszelnicka 
et al. where no correlation was seen between the IR as measured by 
HOMA and Gensini score in 151 non-diabetic men [19].
Similarly, Vonbank et al. [20] reported no difference in HOMA-IR among 
986 patients who underwent coronary angiography with varying 
severity of disease, irrespective of diabetes status and a study in 797 
men by Solymoss et al. [21] found no association between the number 
of coronary arteries with >50% stenosis and fasting insulinemia, a 
surrogate marker for IR.
However, studies in smaller groups (n=38-83) found a positive 
relationship between angiographic CAD extent and IR as assessed by 
insulin suppression test or HOMA-IR [22-24].
Large data also suggest that IR has a pivotal role in atherosclerosis [25]. 
IR is closely related with an increased risk of cardiovascular 
disease [26]. The endothelial dysfunction which develops due to altered 
insulin signaling in the endothelial cells has resulted in the increased 
susceptibility to cardiovascular disease [26].
The third U.S. National Health and Nutrition Examination Survey III 
during a mean follow-up of 8.5 years found that there was independent 
association of HOMA-IR and mortality from cardiovascular events in 
non-diabetic adults [27]. Similar results were also obtained by a meta-
analysis, which concluded that there 46% increase in the relative risk of 
symptomatic CAD per 1-SD increment in HOMA-IR [28].
In a cross-sectional study, a significant positive linear correlation 
between IR and severity of coronary atherosclerosis has been shown 
in diabetics between the Indian populations. In individuals with Type 2 
diabetes mellitus, the evolution of insulin resistance is unique.
It precedes the onset of diabetes and remains fairly constant throughout 
the disease in spite of controlling for controlling for conventional risk 
factors [29]. In the U.K prospective diabetes study, the IR as measured 
by HOMA-IR method has been shown to be relatively stable during the 
many years of treatment even after with the conventional treatment of 
Type 2 diabetes mellitus, [30,31].
However, in non-diabetics, IR seems to be fluctuating, and that is why 
we were not able to appreciate the correlation with severity of CAD. 
Therefore, it is hypothesized that the morbidity is associated with 
elevated levels of HOMA-IR in non-diabetic CAD patients but not the 
severity.
Since major therapeutic decision depends on the severity of CAD, it 
is important to identify the factor responsible for severe CAD in non-
diabetic individuals. But in this study, IR and other conventional risk 
factors of CAD were not associated with severity of CAD in non-diabetic 
patients. Thus, further prospective studies are needed to find out which 
of these risk factors is contributing to the severity of CAD in non-
diabetic individuals.











HOMA-IR: Homeostasis model assessment-insulin resistance, TC/HDL: Total 
cholesterol/high density lipoprotein, LDL: Low density lipoprotein, 
HbA1c: Hemoglobin A1C, FBS: Fasting blood sugar, SD: Standard deviation, 
BMI: Body mass index
Fig. 1: Scatter plot showing, no correlation between severity 
of coronary artery disease (Gensini score) and log of insulin 
resistance (homeostasis model assessment-insulin resistance) in 
non-diabetes
Table 2: Correlation between Gensini score, insulin resistance, 
and other conventional risk factors CAD
Variables Gensini score
r value p value
Log HOMA-IR −0.053 0.645
TC −0.003 0.979




Waist circumference −0.156 0.171
BMI 0.030 0.794
HOMA-IR: Homeostasis model assessment-insulin resistance; TC/HDL: Total 
cholesterol/high density lipoprotein, LDL: Low density lipoprotein, 
HbA1C: Hemoglobin A1C, BMI: Body mass index, CAD: Coronary artery disease
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LIMITATIONS
This study has several limitations, as this study included only patients 
with proven CAD, there is no control group. The study population and 
size were limited. The cross-sectional design and a single center study.
CONCLUSIONS
The findings of the study indicate that though HOMA-IR is not associated 
with severity of the disease in the non-diabetic population, and hence 
the role of insulin resistance leading to severe CAD would be limited 
in non-diabetes. More research is needed to study how IR influences 
coronary atherosclerosis in non-diabetics.
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